The efficacy of anakinra in an adolescent with colchicine-resistant familial Mediterranean fever

Colchicine is the treatment of choice in familial Mediterranean fever (FMF) for the prevention of both attacks and secondary amyloidosis. The overall nonresponder rate is about 5–10%. Anakinra is known to have good effectiveness in a severe autoinflammatory syndrome [chronic infantile neurological c...

Descripción completa

Detalles Bibliográficos
Autores principales: Calligaris, Lorenzo, Marchetti, Federico, Tommasini, Alberto, Ventura, Alessandro
Formato: Texto
Lenguaje:English
Publicado: Springer-Verlag 2007
Materias:
Short Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2292480/
https://www.ncbi.nlm.nih.gov/pubmed/17588171
http://dx.doi.org/10.1007/s00431-007-0547-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2292480/
https://www.ncbi.nlm.nih.gov/pubmed/17588171
http://dx.doi.org/10.1007/s00431-007-0547-3

Ejemplares similares